نتائج البحث - "Ommen, HB"

المصدر: Ommen, HB, Brændstrup, K & Hasle, H 2009, ' WT1 as MRD marker in myeloid leukemia of Down syndrome ', Aarhus, Denmark, 06/06/2009-09/06/2009, .

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pure_au_____::63b377a37e5594c0418d2ab06c690c0c
https://pure.au.dk/portal/da/publications/wt1-as-mrd-marker-in-myeloid-leukemia-of-down-syndrome(558b08c0-1182-11df-b95d-000ea68e967b).html

8

دورية أكاديمية

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

View this record from ISI Web of Science

9

دورية أكاديمية

Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission.

المؤلفون: Othman J; Department of Medical and Molecular Genetics, King's College London, London, United Kingdom.; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; Faculty of Medicine and Health, University of Sydney, Sydney, Australia., Potter N; Department of Medical and Molecular Genetics, King's College London, London, United Kingdom., Ivey A; Alfred Hospital and Monash University, Melbourne, Australia., Jovanovic J; Department of Medical and Molecular Genetics, King's College London, London, United Kingdom., Runglall M; Department of Medical and Molecular Genetics, King's College London, London, United Kingdom.; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Freeman SD; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Gilkes A; Department of Haematology, Cardiff University, Cardiff, United Kingdom., Thomas I; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom., Johnson S; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom., Canham J; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom., Cavenagh J; Department of Haemato-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom., Kottaridis P; Department of Haematology, University College London Hospital NHS Foundation Trust, London, United Kingdom., Arnold C; Clinical Haematology, Belfast City Hospital, Belfast, United Kingdom., Ommen HB; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark., Overgaard UM; Department of Haematology, Copenhagen University Hospital, Copenhagen, Denmark., Dennis M; The Christie NHS Foundation Trust, Manchester, United Kingdom., Burnett A; Paul O'Gorman Leukaemia Centre, Glasgow University, Glasgow, United Kingdom., Wilhelm-Benartzi C; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom., Dillon R; Department of Medical and Molecular Genetics, King's College London, London, United Kingdom.; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Russell NH; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.

المصدر: Blood [Blood] 2024 May 09; Vol. 143 (19), pp. 1931-1936.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation* , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/therapy , Neoplasm, Residual* , Nucleophosmin*, Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Young Adult ; fms-Like Tyrosine Kinase 3/genetics ; Induction Chemotherapy ; Mutation ; Prospective Studies ; Remission Induction ; Transplantation, Homologous

10

دورية أكاديمية

Molecular, clinical and therapeutic determinants of outcome in NPM1 mutated AML.

المؤلفون: Othman J; Faculty of Medicine and Health, University of Sydney, Australia., Potter N; King's College, London, London, United Kingdom., Ivey A; The Alfred Hospital, Melbourne, Australia., Tazi Y; The Rockefeller University, Cornell, MSKCC, NYC, New York, United States., Papaemmanuil E; MSKCC, NYC, United Kingdom., Jovanovic J; King's College London, London, United Kingdom., Freeman SD; University of Birmingham, UK, Birmingham, United Kingdom., Gilkes AF; Cardiff University, Cardiff, United Kingdom., Gale RE; University College London, London, United Kingdom., Rapoz-D'Silva T; University College London, London, United Kingdom., Runglall M; King's College, London, London, United Kingdom., Kleeman M; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Dhami P; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Thomas I; Cardiff University, Cardiff, United Kingdom., Johnson S; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom, cardiff, United Kingdom., Canham J; Cardiff University, Cardiff, United Kingdom., Cavenagh JD; St. Bartholomew's Hospital, London, United Kingdom., Kottaridis P; UNIVERSITY COLLEGE LONDON HOSPITAL, LONDON, United Kingdom., Arnold C; Belfast City Hospital, Belfast, United Kingdom., Ommen HB; Aarhus University Hospital, Aarhus N, Denmark., Overgaard UM; Copenhagen University Hospital, Copenhagen, Denmark., Dennis M; Christie NHS Foundation Trust, Manchester, United Kingdom., Burnett AK -; Formerly Cardiff University, Isle of Arran, United Kingdom., Wilhelm-Benartzi CS; Cardiff University, Cardiff, United Kingdom., Huntly BJ; Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom., Russell NH; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Dillon RJ; King's College, London, London, United Kingdom.

المصدر: Blood [Blood] 2024 May 01. Date of Electronic Publication: 2024 May 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

تنقيح النتائج